Multidrug-Resistant Tuberculosis and Bedaquiline

被引：14
|
作者：
Salfinger, Max [1 ]
Somoskovi, Akos [2 ]
机构：
[1] Natl Jewish Hlth, Denver, CO 80206 USA
[2] Skaraborg Hosp, Skovde, Sweden
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2014年 / 371卷 / 25期
关键词：
D O I：
10.1056/NEJMc1412235
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2435 / 2436
页数：2
相关论文
共 50 条
  • [31] Multidrug-resistant tuberculosis and beyond: an updated analysis of the current evidence on bedaquiline
    Pontali, Emanuele
    D'Ambrosio, Lia
    Centis, Rosella
    Sotgiu, Giovanni
    Migliori, Giovanni Battista
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (03)
  • [32] Acquisition of clofazimine resistance following bedaquiline treatment for multidrug-resistant tuberculosis
    Liu, Yuhong
    Gao, Jingtao
    Du, Jian
    Shu, Wei
    Wang, Lu
    Wang, Yufeng
    Xue, Zhongtan
    Li, Liang
    Xu, Shaofa
    Pang, Yu
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 102 : 392 - 396
  • [33] Bedaquiline: An Insight Into its Clinical Use in Multidrug-Resistant Pulmonary Tuberculosis
    Ahmad, Asad
    Akhtar, Juber
    Ahmad, Mohammad
    Badruddeen
    Khan, Mohammad Irfan
    Wasim, Rufaida
    Islam, Anas
    Singh, Aditya
    DRUG RESEARCH, 2024, 74 (06) : 269 - 279
  • [34] Bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis: a multicentre cohort study in Korea
    Kim, Cheon Tae
    Kim, Tae-Ok
    Shin, Hong-Joon
    Ko, Young Chun
    Choe, Yeong Hun
    Kim, Hak-Ryul
    Kwon, Yong-Soo
    EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (03)
  • [35] Effectiveness of Bedaquiline Use beyond Six Months in Patients with Multidrug-Resistant Tuberculosis
    Trevisi, Letizia
    Hernan, Miguel A.
    Mitnick, Carole D.
    Khan, Uzma
    Seung, Kwonjune J.
    Rich, Michael L.
    Bastard, Mathieu
    Huerga, Helena
    Melikyan, Nara
    Atwood, Sidney A.
    Avaliani, Zaza
    Llanos, Felix
    Manzur-ul-Alam, Mohammad
    Zarli, Khin
    Binegdie, Amsalu Bekele
    Adnan, Sana
    Melikyan, Arusyak
    Gelin, Alain
    Isani, Afshan K.
    Vetushko, Dmitry
    Daugarina, Zhenisgul
    Nkundanyirazo, Patrick
    Putri, Fauziah Asnely
    Vilbrun, Charles
    Khan, Munira
    Hewison, Catherine
    Khan, Palwasha Y.
    Franke, Molly F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207 (11) : 1525 - 1532
  • [36] Modeling the impact of bedaquiline treatment strategies on the multidrug-resistant tuberculosis burden in India
    Mehra, M.
    Kambili, C.
    Potluri, R.
    Rhines, A.
    Singh, V.
    Thomas, A.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2017, 21 (08) : 902 - 909
  • [37] Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Concern to Bedaquiline: Authors' Reply
    Kang, Yewon
    Mok, Jeongha
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2022, 85 (01) : 98 - 99
  • [38] Cost-effectiveness of Bedaquiline for the Treatment of Multidrug-resistant Tuberculosis in the Republic of Korea
    Park, Hae-Young
    Ku, Hye-min
    Sohn, Hyun-Soon
    Seo, Hae-Sook
    Lee, Hyun Yung
    Lim, Kyung Hwa
    Kwon, Jin-Won
    CLINICAL THERAPEUTICS, 2016, 38 (03) : 655 - 667
  • [39] Bedaquiline-induced psoriasiform drug eruption in a patient of multidrug-resistant tuberculosis
    Kowe, Priyanka
    Zatakia, Srushti
    Chethan, M. V.
    Dhurat, Rachita
    INDIAN JOURNAL OF PHARMACOLOGY, 2024, 56 (03) : 228 - 230
  • [40] Bedaquiline versus placebo for management of multidrug-resistant tuberculosis: A systematic review Reply
    Charan, Jaykaran
    Reljic, Tea
    Kumar, Ambuj
    INDIAN JOURNAL OF PHARMACOLOGY, 2016, 48 (04) : 467 - 467
12345